1-8 of 8
Lucia Nogova
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group

Brief Report
Dennis A. Eichenauer, Michael Fuchs, Annette Pluetschow, Beate Klimm, Teresa Halbsguth, Boris Böll, Bastian von Tresckow, Lucia Nogová, Peter Borchmann, Andreas Engert
Journal: Blood
Blood (2011) 118 (16): 4363–4365.
https://doi.org/10.1182/blood-2011-06-361055
Published: 2011
Journal Articles

Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

Clinical Trials & Observations
Teresa V. Halbsguth, Lucia Nogová, Horst Mueller, Michal Sieniawski, Dennis A. Eichenauer, Thomas Schober, Hiltrud Nisters-Backes, Peter Borchmann, Volker Diehl, Andreas Engert, Andreas Josting
Journal: Blood
Blood (2010) 116 (12): 2026–2032.
https://doi.org/10.1182/blood-2009-11-253211
Published: 2010
Journal Articles

The Newly Developed Modified BEACOPP-Regimen (BACOPP) Is Active and Feasible in Elderly Patients with Hodgkin Lymphoma: Results of a Phase II Study of the German Hodgkin Study Group (GHSG)

Horst Mueller, Lucia Nogova, Dennis A Eichenauer, Teresa Halbsguth, Hiltrud Nisters-Backes, Thomas Schober, Hartmut Eimermacher, Peter Borchmann, Michael Fuchs, Andreas Engert, Andreas Josting
Journal: Blood
Blood (2008) 112 (11): 2600.
https://doi.org/10.1182/blood.V112.11.2600.2600
Published: 2008
Journal Articles

Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG)

Clinical Trials & Observations
Michal Sieniawski, Thorsten Reineke, Lucia Nogova, Andreas Josting, Beate Pfistner, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2008) 111 (1): 71–76.
https://doi.org/10.1182/blood-2007-02-073544
Published: 2008
Includes: Supplemental data
Journal Articles

Prognostic Factors and Treatment Outcome in Lymphocyte Predominant and Classical Hodgkin’s Lymphoma: A Comprehensive Analysis of the German Hodgkin Study Group.

Lucia Nogova, MD, Thorsten Reineke, Corinne Brillant, Thomas Ruediger, Prof, Hans K. Mueller-Hermelink, Prof., Henning Bredenfeld, MD, Andreas Josting, MD, Rolf P. Mueller, Prof., Volker Diehl, Prof., Andreas Engert, Prof.
Journal: Blood
Blood (2006) 108 (11): 97.
https://doi.org/10.1182/blood.V108.11.97.97
Published: 2006
Journal Articles

A New BACOPP Schedule Is Feasible and Effective in Elderly Hodgkin’s Lymphoma Patients - Interim Results of a Multicenter Phase-II Trial of the German Hodgkin Study Group (GHSG).

Lucia Nogova, MD, Michal Sieniawski, MD, Hildrud Nisters-Backes, Veronika Jennissen, MD, Volker Diehl, MD, Andreas Engert, MD, Andreas Josting, MD
Journal: Blood
Blood (2005) 106 (11): 4735.
https://doi.org/10.1182/blood.V106.11.4735.4735
Published: 2005
Journal Articles

Comparison of Patients (Pts) Characteristic and Treatment Outcomes in Lymphocyte-Predominant (LPHD) and Classical Hodgkin’s Disease (cHD): A Report from the German Hodgkin Lymphoma Study Group (GHSG).

Lucia Nogova, MD, Thorsten Reineke, Andreas Josting, MD, Karolin Behringer, MD, Beate Pfistner, PhD, Volker Diehl, MD, Andreas Engert, MD
Journal: Blood
Blood (2004) 104 (11): 1309.
https://doi.org/10.1182/blood.V104.11.1309.1309
Published: 2004
Journal Articles

Secondary Amenorrhoea after Hodgkin’s Lymphoma Is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral Contraceptives during Therapy: A Report from the German Hodgkin Lymphoma Study Group (GHSG).

Karolin Behringer, MD, Kai Breuer, MD, Thomas Reineke, MSc, Michael May, MD, Lucia Nogova, MD, Beate Klimm, MD, Volker Diehl, MD, Andreas Engert, MD
Journal: Blood
Blood (2004) 104 (11): 1314.
https://doi.org/10.1182/blood.V104.11.1314.1314
Published: 2004